Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec;65(6):1790-5.
doi: 10.1086/302648.

Complete inactivation of the TSC2 gene leads to formation of hamartomas

Complete inactivation of the TSC2 gene leads to formation of hamartomas

K S Au et al. Am J Hum Genet. 1999 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure  1
Figure 1
Testing of DNA samples from family HOU23, including members HOU23-04 (unaffected father), HOU23-05 (unaffected mother), HOU23-02 (unaffected child), HOU23-03 (affected child), and HOU23-01 (affected child), as depicted on pedigree shown above gels. The family represents an example of germline mosaicism, details of which are reported elsewhere (Rose et al. 1999). Individual lanes are labeled to indicate tissue from which DNA was extracted: B = blood lymphocytes, T = AML sample from HOU23-03, lT = left kidney AML, rT1–rT6 = six individual right-kidney AML samples, and rNK = right-kidney normal tissue from HOU23-01. Decrease in intensity of bands indicating loss of the wild-type TSC2 allele in some cells of the AMLs from patient HOU23-01 are observed in AC. A, Marker D16S525 is located ∼95 kb telomeric to the 5′ end of TSC2. Both HOU23-01 and HOU23-03 are heterozygous, with alleles of 149 bp and 161 bp present. The 161-bp allele was significantly reduced in the lT, rT1, rT2, rT5, and rT6 of HOU23-01, whereas the 149-bp and 161-bp alleles were of equal intensity in rT3 or rT4 of HOU23-01 and in the AML (T) from HOU23-03. B, Patients were informative for the EcoRV polymorphism in exon 40 of TSC2, with heterozygotes showing three bands at 579, 389, and 190 bp, respectively. Decrease in the intensity of the wild-type allele was found in the same AML DNAs (lT, rT1, rT2, rT5, and rT6) as in A, indicating LOH for the wild-type allele in some cells from which the DNA was extracted. C, The marker D16S665 is located ∼75 kb from the 3′ end of TSC2. The father (HOU23-04) is heterozygous for the marker, with alleles of 142 and 88 bp, and the mother is homozygous for the 124-bp allele. The results showed the same five AMLs (lT, rT1, rT2, rT5, and rT6) with decreased intensity of the paternal 88-bp allele, while retaining the maternal 124-bp allele. The paternal 142-bp allele is not inherited by any of the offspring in the family.
Figure  2
Figure 2
An intragenic deletion of TSC2 is the second (somatic) mutation in two FAs from patient TS93-41. Studies using markers within and flanking TSC2 showed no evidence for LOH in the three FAs obtained. A, Southern analysis of DNA from two FAs (FA1 and FA2), performed by means of a TSC2 cDNA probe spanning nucleotide 1–1197, revealed junction fragments of ∼7.5 kb with HindIII digestion. No junction fragment was detected with the lymphocyte DNA (lane B), even when a much higher (approximately fivefold) concentration of DNA was used. B, Diagram illustrating probes tested, restriction map for BamHI and HindIII of the TSC2 gene, predicted fragment sizes, and approximate size and location of deletion.

Similar articles

Cited by

References

Electronic-Database Information

    1. GenBank, http://www.ncbi.nlm.nih.gov/Genbank/GenbankOverview.html (for X75621)
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for TSC [MIM 191092]) - PubMed

References

    1. Ahlsen G, Gilberg IC, Lindblom R, Gilberg C (1994) Tuberous sclerosis in western Sweden. Arch Neurol 51:76–81 - PubMed
    1. Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, et al (1998) Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 83:2208–2216 - PubMed
    1. Au K-S, Rodriguez JA, Finch JL, Volcik KA, Roach ES, Delgado MR, Rodriguez E Jr, et al (1998) Germline mutations of the TSC2 gene in 90 tuberous sclerosis patients. Am J Hum Genet 62:286–294 - PMC - PubMed
    1. Au K-S, Rodriguez JA, Rodriguez E Jr, Dobyns WB, Delgado MR, Northrup H (1997) Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16. Hum Mutat 9:23–29 - PubMed
    1. Bjornsson J, Short MP, Kwaitkowski DJ, Henske EP (1996) Tuberous sclerosis-associated renal cell carcinoma: clinical, pathological, and genetic features. Am J Pathol 149:1201–1208 - PMC - PubMed

Publication types

MeSH terms

-